Walleye Trading
BHVN

Walleye Trading’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Walleye Trading’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-123,100
Closed -$18.6M – 5856
2022
Q3 		$18.6M Buy
123,100
+113,700
+1,210% +$16.9M 0.06% 366
2022
Q2 		$1.37M Buy
+9,400
New +$1.2M ﹤0.01% 1971
2022
Q1 		– Sell
-600
Closed -$83K – 6264
2021
Q4 		$83K Sell
600
-1,100
-65% -$140K ﹤0.01% 4477
2021
Q3 		$236K Sell
1,700
-300
-15% -$37.5K ﹤0.01% 3695
2021
Q2 		$194K Buy
+2,000
New +$162K ﹤0.01% 3961
2021
Q1 		– Sell
-600
Closed -$51K – 5726
2020
Q4 		$51K Buy
+600
New +$50.8K ﹤0.01% 4179
2020
Q1 		– Sell
-13,800
Closed -$751K – 4952
2019
Q4 		$751K Sell
13,800
-25,700
-65% -$1.27M 0.01% 2052
2019
Q3 		$1.65M Sell
39,500
-42,100
-52% -$1.78M 0.01% 1209
2019
Q2 		$3.57M Buy
81,600
+64,700
+383% +$3.65M 0.03% 650
2019
Q1 		$870K Sell
16,900
-5,600
-25% -$242K 0.01% 1794
2018
Q4 		$832K Buy
+22,500
New +$811K 0.01% 1921

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Walleye Trading's BHVN Position: Q3 2022 in Review

Walleye Trading sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 3,046 shares — an estimated $451K sold.

Walleye Trading first reported a position in BHVN in Q1 2019 and held it in 5 quarters. The position peaked at $635K in Q1 2019. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Walleye Trading reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 3,046 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $451K.
  • Walleye Trading first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2019 and held it in 5 quarters.
  • Walleye Trading's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $635K in Q1 2019.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.